News: Detail
9/7/2009 - Life Vest -- The First Wearable Defibrillator


 
The LifeVest wearable cardioverter defibrillator is a therapeutic option in the continuum of care for your patients at risk for sudden cardiac death.
  • LifeVest does not require any bystander intervention.
  • LifeVest will attempt treatment for 100% of tachyarrhythmic SCA.
  • LifeVest has a 98% first shock success rate.
  • LifeVest has a 92% shock event survival with patients either staying at home or admitted conscious to the ER
  • Over 19,000 patients have worn the LifeVest.
  • LifeVest is listed as a therapeutic option in ACC/AHA/ESC Guidelines for the Management of Patients with Ventricular Arrhythmias and the prevention of Sudden Cardiac Death.
  • LifeVest is a Class I recommendation in the 2006 International Society for Heart and Lung Transplantation Guidelines for the Care of Cardiac Transplant Candidates.
Call or write CrashCarts.com if you want to Make LifeVest Part of Your Continuum of Care for Your Patients
Toll Free 888-989-6337 or email president@CrashCarts.com